Use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation - Messages from the 2018 EHRA

被引：4
作者：
Tomaszuk-Kazberuk, Anna [1 ,2 ]
Koltowski, Lukasz [1 ,3 ]
Balsam, Pawel [1 ,3 ]
Kozinski, Marek [1 ,4 ]
Kaplon-Cieslicka, Agnieszka [1 ,3 ]
Kupczynskal, Karolina [1 ,5 ]
Domienik-Karlowicz, Justyna [1 ,6 ]
Budaj-Fidecka, Anna [1 ,3 ]
Buszman, Piotr [1 ,7 ,8 ]
Wybraniec, Maciej [1 ,9 ]
Burchardt, Pawel [1 ,10 ,11 ]
Michalski, Blazej [1 ,5 ]
Jaguszewski, Milosz J. [1 ,12 ]
机构：
[1] Polish Cardiac Soc, Club 30, Krakow, Poland
[2] Med Univ Bialystok, Dept Cardiol, Bialystok, Poland
[3] Med Univ Warsaw, Dept Cardiol 1, Ul Banacha 1a, PL-02097 Warsaw, Poland
[4] Nicolaus Copernicus Univ, Coll Med, Dept Principles Clin Med, Bydgoszcz, Poland
[5] Med Univ Lodz, W Bieganski Hosp, Dept Cardiol, Lodz, Poland
[6] Med Univ Warsaw, Dept Internal Med & Cardiol, Ctr Diag & Treatment Venous Thromboembolism, Warsaw, Poland
[7] Amer Heart Poland, Ctr Cardiovasc Res & Dev, Katowice, Poland
[8] Med Univ Silesia, Clin Dept Cardiol 3, Silesian Ctr Heart Dis, Zabrze, Poland
[9] Med Univ Silesia, Sch Med Katowice, Dept Cardiol 1, Katowice, Poland
[10] Poznan Univ Med Sci, Dept Biol & Lipid Disorders, Poznan, Poland
[11] J Strus Hosp, Dept Cardiol, Poznan, Poland
[12] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland
来源：
CARDIOLOGY JOURNAL | 2018年 / 25卷 / 04期
关键词：
PROTHROMBIN COMPLEX CONCENTRATE; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; ASSAYS LABORATORY RECOMMENDATIONS; ASSOCIATION PRACTICAL GUIDE; HEALTH-CARE PROFESSIONALS; DAILY DOSING FREQUENCY; DRUG-DRUG INTERACTION; FACTOR XA INHIBITOR; THROMBOEMBOLIC EVENTS;
D O I：
10.5603/CJ.2018.0080
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：423 / 440
页数：18
相关论文
共 50 条
  • [21] The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation
    Kuznetsov, Sofya
    Barcelona, Robert
    Josephson, Richard A.
    Mohan, Sri K. Madan
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (05)
  • [22] Pros and Cons of Vitamin K Antagonists and Non-Vitamin K Antagonist Oral Anticoagulants
    Riva, Nicoletta
    Ageno, Walter
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02) : 178 - 187
  • [23] Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
    Hong, Keun-Sik
    [J]. JOURNAL OF STROKE, 2019, 21 (03) : 259 - 275
  • [24] Non-vitamin K antagonist oral anticoagulants (NOACs) postpercutaneous coronary intervention: a network meta-analysis
    Al Said, Samer
    Alabed, Samer
    Kaier, Klaus
    Tan, Audrey R.
    Bode, Christoph
    Meerpohl, Joerg J.
    Duerschmied, Daniel
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (12):
  • [25] Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
    Gorczyca, Iwona
    Jelonek, Olga
    Uzieblo-Zyczkowska, Beata
    Chrapek, Magdalena
    Maciorowska, Malgorzata
    Wojcik, Maciej
    Blaszczyk, Robert
    Kaplon-Cieslicka, Agnieszka
    Gawalko, Monika
    Budnik, Monika
    Tokarek, Tomasz
    Rajtar-Salwa, Renata
    Bil, Jacek
    Wojewodzki, Michal
    Szpotowicz, Anna
    Bednarski, Janusz
    Bakula-Ostalska, Elwira
    Tomaszuk-Kazberuk, Anna
    Szyszkowska, Anna
    Welnicki, Marcin
    Mamcarz, Artur
    Wozakowska-Kaplon, Beata
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 14
  • [26] The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
    De Caterina, Raffaele
    Lip, Gregory Y. H.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (08) : 565 - 572
  • [27] Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome
    Sciascia, Savino
    Lopez-Pedrera, Chary
    Cecchi, Irene
    Pecoraro, Clara
    Roccatello, Dario
    Cuadrado, Maria Jose
    [J]. RHEUMATOLOGY, 2016, 55 (10) : 1726 - 1735
  • [28] Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants
    Eikelboom, J. W.
    Kozek-Langenecker, S.
    Exadaktylos, A.
    Batorova, A.
    Boda, Z.
    Christory, F.
    Gornik, I.
    Kekstas, G.
    Kher, A.
    Komadina, R.
    Koval, O.
    Mitic, G.
    Novikova, T.
    Pazvanska, E.
    Ratobilska, S.
    Sutt, J.
    Winder, A.
    Zateyshchikov, D.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (04) : 645 - 656
  • [29] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
    Lee, Hsin-Fu
    Chan, Yi-Hsin
    Chang, Shang-Hung
    Tu, Hui-Tzu
    Chen, Shao-Wei
    Yeh, Yung-Hsin
    Wu, Lung-Sheng
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    See, Lai-Chu
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (05):
  • [30] Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
    Turagam, Mohit K.
    Velagapudi, Poonam
    Flaker, Greg C.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 1431 - 1444
12345